Elligo Health Research on Tuesday announced it, along with Flatiron Health and the University of Chicago, will act as “data partners” in a project being headed by the U.S. Food and Drug Administration.
According to a press release, the project aims to develop and pilot a “common data architecture” which will serve as a centralized point between numerous data sources to streamline patient-centered research using data from health care delivery in clinical settings.
“Our goal at Elligo is not just to facilitate research,” Elligo CEO John Potthoff CEO said in a statement. “We embrace the opportunity to bring these companies together to work toward better data usability and patient outcomes.”
To read the full press release, click here.